The Role of Technology in Newborn Screening.
Publication
, Journal Article
Millington, DS
Published in: N C Med J
2019
This commentary traces the expansion of newborn screening for inherited metabolic disorders during the past 55 years, from the first simple test for phenylketonuria to the current panel of over 35 conditions. Emphasis is placed on the role played by technology and the contributions made by researchers in North Carolina.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N C Med J
DOI
ISSN
0029-2559
Publication Date
2019
Volume
80
Issue
1
Start / End Page
49 / 53
Location
United States
Related Subject Headings
- Phenylketonurias
- North Carolina
- Neonatal Screening
- Metabolic Diseases
- Infant, Newborn
- Humans
- Biomedical Technology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Millington, D. S. (2019). The Role of Technology in Newborn Screening. N C Med J, 80(1), 49–53. https://doi.org/10.18043/ncm.80.1.49
Millington, David S. “The Role of Technology in Newborn Screening.” N C Med J 80, no. 1 (2019): 49–53. https://doi.org/10.18043/ncm.80.1.49.
Millington DS. The Role of Technology in Newborn Screening. N C Med J. 2019;80(1):49–53.
Millington, David S. “The Role of Technology in Newborn Screening.” N C Med J, vol. 80, no. 1, 2019, pp. 49–53. Pubmed, doi:10.18043/ncm.80.1.49.
Millington DS. The Role of Technology in Newborn Screening. N C Med J. 2019;80(1):49–53.
Published In
N C Med J
DOI
ISSN
0029-2559
Publication Date
2019
Volume
80
Issue
1
Start / End Page
49 / 53
Location
United States
Related Subject Headings
- Phenylketonurias
- North Carolina
- Neonatal Screening
- Metabolic Diseases
- Infant, Newborn
- Humans
- Biomedical Technology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences